US equities |
NVDA $240.46 ▲+0.65% SPCX $174.03 ▲+1.72% MU $1,066.27 ▲+0.22% MRVL $286.11 ▲+5.48% AMD $656.19 ▲+3.87% SNDK $1,672.90 ▼-1.83% AVGO $378.62 ▲+4.44% INTC $113.06 ▼-2.69%
FinancialContent

Latest News about MDXX class molecules

Recent news which mentions MDXX class molecules

PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
Tickers MDMA MDXXF NEWS TRUFF
Tags PharmAla MDXX class molecules MDXXF
From Benzinga
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
Tickers MDXXF
Tags Benzinga Cannabis Global
From Benzinga
Terran Biosciences' Four Patent Applications Cover Improved Versions Of Classic Empathogens
Tags Market News Psychedelics Markets
From Benzinga
Clinical Grade 'LaNeo' MDMA Completes Release Testing And Is Ready For Export In Several Dosages
Tags Benzinga News PharmAla Biotech Holdings Inc
From Benzinga